Indefinite Delivery Contract SPE2D226D0001
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract to Avkare, LLC, a for-profit limited liability company. The contract, with a potential value of $31,732,179.00, aims to provide a national supply source for the procurement of pharmaceutical products, medical equipment, and other healthcare supplies by federal agencies including the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs....
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $62,144,789.65 contract has a period of performance through April 2025 and allows the DLA, Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons (BOP) to issue task orders for a variety of pharmaceutical and medical products. The original solicitation sought offers for a...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs National Acquisition Center on July 15, 2024, with a ceiling value of $1,244,773.20. The contract encompasses a one-year base period plus four one-year option periods, with an ultimate completion date of July 14, 2026. The primary product being procured is tenofovir disoproxil fumarate 300 mg tablets, with...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain on October 5, 2022, with a ceiling value of $43.14 million and an ultimate completion date of October 4, 2027. This unrestricted contract, not utilizing any small business set-aside, establishes Avkare as the national requirements supplier for Estradiol Tablets in 8 and 18 count packs to support...
- Avkare LLC has been awarded a $1.637 billion Federal Supply Schedule contract under General Services Administration Schedule 61-IB for Pharmaceuticals and Drugs, effective from June 15, 2023, through June 14, 2028. This multiple-award indefinite delivery contract establishes Avkare as a blanket purchasing agreement provider for pharmaceutical and drug-related products to federal healthcare agencies without set-aside restrictions. The contract includes a Voluntary Temporary Price Reduction...
- Avkare LLC has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Metformin Hydrochloride 24-hour sustained-release tablets in 500mg and 750mg strengths. The contract, effective December 30, 2025, through December 29, 2026, with four one-year option periods, carries a ceiling value of $90.7 million and will serve as a source for multiple federal healthcare agencies including the Department of Defense,...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on August 9, 2021, with a ceiling value of $5.7 million and an ultimate completion date of August 8, 2026. The contract covers the supply of Montelukast HCL chewable tablets, a leukotriene receptor antagonist commonly used in the treatment of asthma and allergic rhinitis. The base year runs from August 9, 2021, through August 8, 2022, followed by four one-year...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 21, 2021, for the supply of Carbidopa/Levodopa immediate-release tablets. This pharmaceutical contract carries a ceiling value of $21.74 million and spans a base performance period from June 21, 2021, through June 20, 2022, with four one-year option periods extending through the June 20, 2026 ultimate completion date. The contract was awarded without...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 17, 2025, with a ceiling value of $20.31 million to supply Abiraterone Acetate 250 milligram tablets. The contract structure includes a one-year base period with four one-year option periods, extending through June 16, 2026. This procurement is unrestricted with no small business set-aside designation, and the contract will support multiple federal...
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee. The contract, valued at $4,619,331.60, is for the supply of phenytoin sodium extended-release capsules to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a one-year base period with four one-year option periods, and allows the...
Avkare LLC has been awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency (DLA) Medical Supply Chain with a ceiling value of $39.51 million and a period of performance extending from October 16, 2025, through October 15, 2030. This unrestricted, fully competitive procurement was established to support the DLA's national requirements for Potassium Chloride Extended Release Tablets, available in 10 milliequivalent and 20 milliequivalent formulations in various bottle counts. The contract structure includes a one-year base period with four one-year renewal options, procured as a commercial item under Federal Acquisition Regulation Part 12. As a firm-fixed price requirements-type contract, it establishes Avkare as the sole source for issuing delivery orders to meet federal healthcare agencies' operational needs for this essential pharmaceutical product. Avkare LLC, a pharmaceutical and medical supply distributor headquartered in Pulaski, Tennessee, is well-positioned to fulfill this requirement based on its extensive experience as a federal healthcare supplier since 2007. The contractor maintains a substantial portfolio of Indefinite Delivery Contracts with multiple federal agencies, including a $1.637 billion General Services Administration Schedule 61-IB contract for pharmaceuticals and drugs and multiple specialized contracts with the Department of Veterans Affairs and DLA Troop Support Medical for generic pharmaceutical products. This award leverages Avkare's proven capability to meet federal pharmaceutical procurement standards and supply chain requirements across the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, Indian Health Service, and other federal beneficiary populations, ensuring reliable access to potassium chloride extended-release tablets throughout the contract performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 10/16/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Potassium Chloride Extended Release Tablets | SPE2D2-24-R-0013 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/2 | 5/14/24, 7:21 AM | |
Potassium Chloride Extended Release Tablets | SPE2D2-24-R-0013 | Defense Logistics Agency Troop Support Medical | Solicitation 2/2 | 9/10/24, 1:59 PM |